Argent BioPharma Expands into Germany's Largest Pharmaceutical Market Argent BioPharma has officially entered Germany's pharmaceutical market, making significant strides with regulatory approvals and operational cost savings.

Argent BioPharma Expands into Germany's Largest Pharmaceutical Market #Germany #Berlin #Argent_BioPharma #CannEpil #CogniCann

Argent BioPharma Secures $4.5 Million to Advance Innovative Therapeutics Argent BioPharma has successfully raised $4.5 million to propel their groundbreaking work in neuro-immune modulation for CNS disorders.

Argent BioPharma Secures $4.5 Million to Advance Innovative Therapeutics #Australia #Argent_BioPharma #CannEpil #Perth #neuro-immunology

Argent BioPharma's US$4.5 Million Capital Raise to Advance Innovative Treatments Argent BioPharma has successfully raised US$4.5 million to enhance its drug development pipeline for CNS and immune-related disorders. The funds will boost clinical studies and operations.

Argent BioPharma's US$4.5 Million Capital Raise to Advance Innovative Treatments #Australia #Argent_BioPharma #Nano-medicine #CannEpil #Perth